Product Information
DISOPYRAMIDE 150 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.5318 per EA under NDC 00093312901. Its NADAC has been published 636 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093312901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DISOPYRAMIDE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA070102On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for DISOPYRAMIDE 150 MG CAPSULE has been published 636 times since Nov 28, 2013, and over the history we have for it it has risen 406.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5318 per EA |
|---|---|
| All-time high | $1.8360 (May 15, 2019) |
| All-time low | $0.2919 (Sep 17, 2014) |
| 52-week high | $1.7091 |
| 52-week low | $1.4367 |
| Median price | $1.4565 |
| Average price | $1.3383 |
| Largest weekly change | +203.5% (Apr 20, 2016) |
| Weeks tracked | 636 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Disopyramide Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DISOPYRAMIDE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DISOPYRAMIDE 150 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.5318 per EA (NDC 00093312901), effective Jun 24, 2026.
How has the price of DISOPYRAMIDE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has risen 406.8%. It has been tracked across 636 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DISOPYRAMIDE 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has ranged from a low of $0.2919 (Sep 17, 2014) to a high of $1.8360 (May 15, 2019), with a median of $1.4565 per EA.
Are there cheaper alternatives to DISOPYRAMIDE 150 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DISOPYRAMIDE 150 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures DISOPYRAMIDE 150 MG CAPSULE?
DISOPYRAMIDE 150 MG CAPSULE (NDC 00093312901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification